IRIS
DE NICOLA, Luca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 10.764
NA - Nord America 9.349
AS - Asia 7.786
SA - Sud America 1.389
AF - Africa 104
Continente sconosciuto - Info sul continente non disponibili 8
OC - Oceania 7
Totale 29.407
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.237
RU - Federazione Russa 4.041
SG - Singapore 2.752
IE - Irlanda 2.168
CN - Cina 1.822
HK - Hong Kong 1.445
BR - Brasile 1.184
UA - Ucraina 1.165
GB - Regno Unito 909
IT - Italia 702
DE - Germania 643
IN - India 477
TR - Turchia 328
FI - Finlandia 320
VN - Vietnam 305
SE - Svezia 299
KR - Corea 298
GR - Grecia 188
JP - Giappone 99
FR - Francia 90
AR - Argentina 83
AT - Austria 55
BD - Bangladesh 54
CA - Canada 46
BE - Belgio 43
EC - Ecuador 36
MX - Messico 36
CZ - Repubblica Ceca 29
NL - Olanda 28
ID - Indonesia 27
ZA - Sudafrica 27
IQ - Iraq 26
ES - Italia 25
PK - Pakistan 24
CO - Colombia 22
MA - Marocco 20
IR - Iran 17
TN - Tunisia 16
VE - Venezuela 16
CL - Cile 14
PY - Paraguay 14
UZ - Uzbekistan 14
PH - Filippine 13
MY - Malesia 11
PL - Polonia 11
IL - Israele 10
KZ - Kazakistan 10
LT - Lituania 10
AE - Emirati Arabi Uniti 9
JM - Giamaica 9
KE - Kenya 9
EU - Europa 8
PE - Perù 8
UY - Uruguay 8
EG - Egitto 6
SA - Arabia Saudita 6
CH - Svizzera 5
SC - Seychelles 5
AU - Australia 4
BO - Bolivia 4
ET - Etiopia 4
GE - Georgia 4
KG - Kirghizistan 4
NI - Nicaragua 4
RS - Serbia 4
AL - Albania 3
BG - Bulgaria 3
DO - Repubblica Dominicana 3
HU - Ungheria 3
LB - Libano 3
MK - Macedonia 3
NP - Nepal 3
OM - Oman 3
PT - Portogallo 3
RO - Romania 3
TH - Thailandia 3
TW - Taiwan 3
BA - Bosnia-Erzegovina 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
DK - Danimarca 2
GA - Gabon 2
HN - Honduras 2
JO - Giordania 2
KH - Cambogia 2
LV - Lettonia 2
NZ - Nuova Zelanda 2
PA - Panama 2
PS - Palestinian Territory 2
RW - Ruanda 2
SN - Senegal 2
SV - El Salvador 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
UG - Uganda 2
AD - Andorra 1
AO - Angola 1
AZ - Azerbaigian 1
BF - Burkina Faso 1
BH - Bahrain 1
Totale 29.387
Salva come PNG Salva come JPEG
Città #
Dublin 2.167
Jacksonville 1.747
Santa Clara 1.508
Hong Kong 1.443
Moscow 1.293
Chandler 1.119
Singapore 938
Chicago 473
Bengaluru 437
Princeton 343
Hefei 316
Seoul 289
Medford 279
Wilmington 269
Beijing 214
Roxbury 210
Boardman 207
Dallas 191
Ashburn 182
Ann Arbor 168
San Mateo 157
Falls Church 133
The Dalles 125
Woodbridge 118
Ho Chi Minh City 116
São Paulo 104
New York 101
Munich 96
Istanbul 95
Naples 88
Cambridge 85
Bremen 75
Hanoi 72
Des Moines 70
Nanjing 69
Jinan 62
Caserta 56
Los Angeles 51
Rio de Janeiro 44
Brussels 42
Norwalk 41
Nuremberg 41
Houston 38
Mountain View 35
Shenyang 35
Belo Horizonte 33
Napoli 33
Saint Petersburg 32
Zhengzhou 32
Rome 30
Guangzhou 28
Milan 28
Brno 27
Vienna 26
Tianjin 24
Helsinki 22
Changsha 21
Curitiba 20
Düsseldorf 19
Ercolano 19
Ningbo 19
Nanchang 18
Shanghai 18
Taizhou 18
Brooklyn 17
Campinas 17
Hangzhou 17
Turku 17
Sorocaba 15
Taiyuan 15
Da Nang 14
Falkenstein 14
Lanzhou 14
London 14
San Francisco 14
Biên Hòa 13
Dhaka 13
Johannesburg 13
Porto Alegre 13
Quito 13
Auburn Hills 12
Bologna 12
Haikou 12
Jiaxing 12
Seattle 12
Tashkent 12
Buenos Aires 11
Haiphong 11
Hebei 11
Salvador 11
Boston 10
Brasília 10
Frankfurt am Main 10
Manaus 10
Tokyo 10
Zanjan 10
Amsterdam 9
Asunción 9
Charlotte 9
Guayaquil 9
Totale 16.654
Salva come PNG Salva come JPEG
Nome #
Ethanol and in-vitro Vascular Reactivity of Rats Mesenteric-Artery 796
A systematic review and meta-analysis suggests obesity predicts onset of chronic kidney disease in the general population 174
Ruolo del refilling plasmatico dopo dialisi alternativa: valutazione dei dati bioimpedenzometrici 160
Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study 154
Empagliflozin in Patients with Chronic Kidney Disease 139
Controversial issues in CKD clinical practice: position statement of the CKD-treatment working group of the Italian Society of Nephrology 138
L'impiego dell’ Emodiafiltrazione con reinfusione endogena (HFR) nell'infiammazione cronica idiopatica: una possibile alternativa terapeutica? 137
Amino acid loss during dialysis treatment 128
Cardiovascular risk factors and disease management in type 2 diabetic patients with diabetic nephropathy 122
Acute and chronic effects of standard hemodialysis and soft hemodiafiltration on interdialytic serum phosphate levels 121
Alterazioni del bilancio idro-elettrolitico nell’insufficienza renale acuta: implicazioni cliniche 121
CHRONIC CYCLOSPORINE A NEPHROTOXICITY - A MORPHOLOGICAL AND FUNCTIONAL-STUDY IN RATS 119
[Hyperuricaemia and Chronic Kidney Disease] 117
Conversion of darbepoetin to low doses of CERA maintains hemoglobin levels in non-dialysis chronic kidney disease patients 116
[Iron deficiency in ND-CKD: from diagnosis to treatment] 116
Independent role of underlying kidney disease on renal prognosis of patients with chronic kidney disease under nephrology care 115
[Anti-diabetics and chronic kidney disease] 115
Absence of acute nephrotoxicity with low doses of cyclosporin: experimental study in the rat 114
Acute cyclosporine renal dysfunction reversed by dopamine infusion in healthy subjects 114
Daily nutrient intake in hemodialysis. 114
Assessment of Achieved Clinic and Ambulatory Blood Pressure Recordings and Outcomes During Treatment in Hypertensive Patients With CKD: A Multicenter Prospective Cohort Study 111
Additive antiproteinuric effect of converting enzyme inhibitor and losartan in normotensive patients with IgA nephropathy 111
Acute increase in plasma osmolality as a cause of hyperkalemia in patients with renal failure 111
Assessment of achieved clinic and ambulatory BP recordings and outcomes during treatment in hypertensive patients with CKD: a multicenter prospective cohort study. 109
[Clinical experience with ferric carboxymaltose in non-dialysis chronic kidney disease] 109
Antiproteinuric response to add-on aliskiren in proteinuric patients treated with dual blockade of the renin-angiotensin system: a 12-month prospective uncontrolled study 108
Antiproteinuric Response to Dual Blockade of RAS in Primary Glomerulonephritis: Meta-Analysis and Meta-Regression 107
Achievement of target blood pressure levels in chronic kidney disease: a salty question ? 104
Cardiorenal prognosis by residual proteinuria level in diabetic chronic kidney disease: pooled analysis of four cohort studies 104
Mesangial hypercellularity predicts antiproteinuric response to dual blockade of RAS in primary glomerulonephritis 103
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 103
Acute renal and immunological effects of low-dose cyclosporin in humans 102
Short-term blood pressure variability in nondialysis chronic kidney disease patients: correlates and prognostic role on the progression of renal disease 102
Associations of Left Ventricular Hypertrophy and Geometry with Adverse Outcomes in Patients with CKD and Hypertension 102
Clinical management of the patient affected with acute renal failure (ARF) secondary to volume depletion 101
Abnormalities of bioimpedance measures in overweight and obese hemodialyzed patients 101
Acute cyclosporine A nephrotoxicity 101
[Epidemiology and prognosis of chronic kidney disease in Italy] 101
Assesement of achieved clinic and ambulatory blood pressure recordings and outcomes during treatment in hypertensive patients wih CKD: a multicenter prospective cohort study 100
[Census of the renal and dialysis units by Italian Society of Nephrology: structure and organization for renal patient assistance in Italy (2014-2015)] 100
Approach to hyponatremia according to the clinical setting: Consensus statement from the Italian Society of Endocrinology (SIE), Italian Society of Nephrology (SIN), and Italian Association of Medical Oncology (AIOM) 100
Disfunzione renale nell’anziano: processo fisiologico o malattia? 99
Epidemiology of chronic kidney disease in Italy: the CARHES study 99
Renal Disease 98
[Peritoneal dialysis catheter infection with abscess of the abdominal wall in a ADPKD patient] 98
Management of hypertension in patients with CKD: differences between primary and tertiary care settings 97
Area Deprivation and Risk of Death and CKD Progression: Long-Term Cohort Study in Patients under Unrestricted Nephrology Care 97
Burden of resistant hypertension in hypertensive patients with non-dialysis chronic kidney disease 96
Prevalence and Prognosis of Mild Anemia in Non-Dialysis CKD: A Prospective Cohort Study in Outpatient Renal Clinics 96
A new diuretic: the Atrial Natriuretic Peptide 96
Early effects of contrast media on renal hemodynamics and tubular function in chronic renal failure 95
Prevalence and cardiovascular risk profile of chronic kidney disease in Italy: results of the 2008-12 National Health Examination Survey 95
Management of hypertension in chronic kidney disease 95
Ruolo dell’ossido nitrico nella regolazione dell’emodinamica glomerulare 95
Inibizione dell’angiotensina II e proteinuria in pazienti con glomerulonefrite IgA mesangiale 95
Alterations of hydro-electrolyte balance in acute renal failure: clinical implications 95
Anaemia management in non-dialysis chronic kidney disease: flexibility of target to target stability? 94
Blood pressure variability, mortality, and cardiovascular outcomes in CKD patients 94
15-year-change of phenotype and prognosis in non-dialysis CKD patients referred to a nephrology clinic 93
Italian audit on therapy of hypertension in chronic kidney disease: the TABLE-CKD study 93
Management of hypertension in chronic kidney disease: the Italian multicenter study. 93
Role of paracalcitol in the management of non-dialysis CKD: state of art and unmeet needs. 93
Epidemiology of CKD Regression in Patients under Nephrology Care 93
[Hyperkalemia treatment in chronic kidney disease patients: overview on new cation exchange resins and possible therapeutic approaches] 93
Effects of efficiency and length of acetate-free biofiltration session on postdialysis solute rebound 92
Prevalence and Prognostic Role of Resistant Hypertension in Chronic Kidney Disease Patients 92
Acute effects of cyclosporine on glomerular dynamics--micropuncture study in the rat 92
Very low-protein diet plus ketoacids in chronic kidney disease and risk of death during end-stage renal disease: an historical, cohort, controlled study. 91
Effect of hemodiafiltration with endogenous reinfusion on overt idiopathic chronic inflammation in maintenance hemodialysis patients: A multicenter longitudinal study. 91
Waist: hip ratio is a better predictor of cardiovascular risk than BMI in patients with moderate CKD 91
Long-term visit-to-visit office blood pressure variability increases the risk of adverse cardiovascular outcomes in patients with chronic kidney disease. 91
Epidemiology of chronic kidney disease in Italy. J Nephrol 2010;23 (Suppl 15):S16-22 90
Epidemiology of chronic kidney disease in Italy 90
Rebound post-dialitico della fosforemia: implicazioni patogenetiche e cliniche 90
Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy 90
Heart Failure in chronic kidney disease: from epidemiology to therapy. 89
Maximal suppression of renin-angiotensin system in nonproliferative glomerulonephritis 89
AMBULATORY BLOOD PRESSURE (ABP) AND RESISTANT HYPERTENSION (RH): TWO INCREMENTAL PREDICTORS OF LONG TERM COMPLICATIONS IN NON-DIALYSIS CKD 89
Comprehensive audit of antihypertensive treatment in patients with chronic renal insufficiency (CRI): The Italian Multicentre survey 89
Epidemiology of chronic kidney disease in Italy: current state and contribution of the CARHES study. 89
Epidemiology of chronic kidney disease in Italy: current situation and contribution of the CARHES study 88
Very low protein diet supplemented with ketoanalogs improves blood pressure control in chronic kidney disease 88
Prevalence and clinical correlates of white coat hypertension in chronic kidney disease 88
Effects of water hardness on urinary risk factors for kidney stones in patients with idiopathic nephrolithiasis 88
Prognostic role of LDL cholesterol in non-dialysis chronic kidney disease: Multicenter prospective study in Italy 88
Acute effects of low-dose cyclosporine on renal function in normal subjects 88
Reversibility of acute cyclosporine renal impairment by dopamine in healthy subjects 88
Types of erythropoiesis-stimulating agents and risk of end-stage kidney disease and death in patients with non-dialysis chronic kidney disease 88
Role of inhibition of atrial natriuretic factor release in the down-regulation of salt excretion 87
Epidemiologia e Prognosi della Malattia Renale Cronica in Italia 87
Acute effects of rapamycin on glomerular dynamics: a micropuncture study in the rat 87
Stage 5-CKD under nephrology care: to dialyze or not to dialyze, that is the question 87
Hyponatremia secondary to inappropriate antidiuretic hormone secretion. 86
Efficacy of erythropoietin on dialysis in patients with Beta-Thalassemia Minor 86
Dopamine counteracts the acute renal effects of cyclosporine in normal subjects 86
Conversion from Epoetin and Darbepoetin to C.E.R.A. in Non-Dialysis CKD Patients: A Multicenter Italian Prospective Study in Nephrology Practice. 86
Anaemia management in non-dialysis chronic kidney disease (CKD) patients: a multicentre prospective study in renal clinics. 86
Risk of ESRD and death in patients with CKD not referred to a nephrologist: a 7-year prospective study 85
Sindrome di Bartter: Un caso clinico 85
Prognosis of CKD Patients Receiving Outpatient Nephrology Care in Italy 85
Totale 10.794
Salva come PNG Salva come JPEG
Categoria #
all - tutte 120.834
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 120.834
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.287 0 0 0 0 0 12 325 279 17 340 250 64
2021/20222.291 188 42 43 82 726 19 44 56 83 145 213 650
2022/20234.441 422 137 318 363 398 342 10 253 1.992 37 75 94
2023/20241.699 150 49 74 172 613 96 38 30 34 32 125 286
2024/20255.897 16 84 81 184 940 893 821 499 637 998 410 334
2025/20269.347 887 1.204 1.168 1.078 1.769 3.241 0 0 0 0 0 0
Totale 29.857